NCT00561496View on ClinicalTrials.gov

Pharmacokinetic Study of the Vaginal Microbicide Agent 1% Tenofovir Gel

PHASE1CompletedINTERVENTIONAL

Enrollment

49

Participants

Timeline

Start Date

March 31, 2007

Primary Completion Date

April 30, 2008

Study Completion Date

April 30, 2008

Conditions

HIV Infections

Interventions

DRUG

Tenofovir gel

Intravaginal (4grams)single dose followed by fourteen days

Trial Locations (3)

15213

University of Pittsburgh Medical Center, Pittsburgh

77030

Advances in Health, Inc, Houston

Unknown

Profamilia, Santo Domingo

Sponsors

Collaborators (1)

Gilead Sciences

All Listed Sponsors

collaborator

International Partnership for Microbicides, Inc.

INDUSTRY

collaborator

Gilead Sciences

INDUSTRY

lead

CONRAD

OTHER

NCT00561496 - Pharmacokinetic Study of the Vaginal Microbicide Agent 1% Tenofovir Gel | Biotech Hunter | Biotech Hunter